MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Phase 1 MAD Data for DA-1726 On April 15, 2025, MetaVia Inc. (NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ...

That's especially true during perimenopause, when constantly-shifting hormones can trigger unwanted weight gain. But for one ...

Drugs firms argue that NICE ’s thresholds are too stingy. Medicines made up around 9% of health spending in Britain in 2018, ...

Skye Bioscience currently trades essentially at cash value, meaning investors who buy in today get a weight loss drug ...

On Alabama's current roster, the most glaring seems to be on the offensive line, especially at offensive tackle.

Indiana football will offer fans a glimpse at a new-look roster on Thursday in the program's annual spring game, here's what ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

has been a rocky year so far for equity investors, but how you respond can make or break a long-term investment strategy.

Experts explain 25 reasons why weight loss efforts may stall, from diet and exercise missteps to medical conditions, and offer actionable solutions to overcome them.